Nicholas Lintzeris

Summary

Country: Australia

Publications

  1. doi Benzodiazepines, methadone and buprenorphine: interactions and clinical management
    Nicholas Lintzeris
    Sydney South West Area Health Service and University of Sydney, Sydney, Australia
    Am J Addict 19:59-72. 2010
  2. doi Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic noncancer pain: do different measures identify the same patients?
    Gabrielle Campbell
    aNational Drug and Alcohol Research Centre, UNSW, Sydney, Australia bSchool of Medicine, University of Tasmania, Hobart, Australia cSydney Medical School, Sydney University, Sydney, Australia dThe Langton Centre, South East Sydney Local Health District SESLHD Drug and Alcohol Services, Sydney, Australia eSt Vincent s Clinical School, UNSW Medicine, UNSW, Sydney, Australia fCentre for Youth Substance Abuse Research, University of Queensland, Brisbane, Australia gNational Addiction Centre, Kings College London, United Kingdom hSchool of Population and Global Health, University of Melbourne, Australia iMurdoch Children s Research Institute, Melbourne, Australia jDepartment of Global Health, School of Public Health, University of Washington, WA, USA
    Pain 157:1489-98. 2016
  3. doi Pharmaceutical Opioid Use and Dependence among People Living with Chronic Pain: Associations Observed within the Pain and Opioids in Treatment (POINT) Cohort
    Gabrielle Campbell
    National Drug and Alcohol Research Centre, UNSW, Sydney, New South Wales, Australia
    Pain Med 16:1745-58. 2015
  4. doi Defined daily doses (DDD) do not accurately reflect opioid doses used in contemporary chronic pain treatment
    Suzanne Nielsen
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia
    Pharmacoepidemiol Drug Saf . 2017
  5. doi Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilization
    Suzanne Nielsen
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales, Australia The Langton Centre, South East Sydney Local Health District SESLHD Drug and Alcohol Services, Sydney, New South Wales, Australia
    Pain Med 16:356-66. 2015
  6. ncbi Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation
    Louisa Degenhardt
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia
    Med J Aust 191:161-5. 2009
  7. doi Comparing treatment-seeking codeine users and strong opioid users: Findings from a novel case series
    Suzanne Nielsen
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia Drug and Alcohol Services, South Eastern Sydney Local Health District, Sydney, Australia
    Drug Alcohol Rev 34:304-11. 2015
  8. pmc Cohort protocol paper: the Pain and Opioids In Treatment (POINT) study
    Gabrielle Campbell
    National Drug and Alcohol Research Centre, UNSW, Sydney, NSW 2052, Australia
    BMC Pharmacol Toxicol 15:17. 2014
  9. doi Opioid agonist doses for oxycodone and morphine dependence: Findings from a retrospective case series
    Suzanne Nielsen
    National Drug and Alcohol Centre, University of New South Wales, Sydney, Australia
    Drug Alcohol Rev . 2016
  10. ncbi The sources of pharmaceuticals for problematic users of benzodiazepines and prescription opioids
    Suzanne Nielsen
    Discipline of Addiction Medicine, University of Sydney, Sydney, NSW, Australia
    Med J Aust 199:696-9. 2013

Collaborators

Detail Information

Publications23

  1. doi Benzodiazepines, methadone and buprenorphine: interactions and clinical management
    Nicholas Lintzeris
    Sydney South West Area Health Service and University of Sydney, Sydney, Australia
    Am J Addict 19:59-72. 2010
    ..An overview of treatment approaches for managing BZD use in this population is presented, including strategies for minimizing abuse and addressing BZD dependence...
  2. doi Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic noncancer pain: do different measures identify the same patients?
    Gabrielle Campbell
    aNational Drug and Alcohol Research Centre, UNSW, Sydney, Australia bSchool of Medicine, University of Tasmania, Hobart, Australia cSydney Medical School, Sydney University, Sydney, Australia dThe Langton Centre, South East Sydney Local Health District SESLHD Drug and Alcohol Services, Sydney, Australia eSt Vincent s Clinical School, UNSW Medicine, UNSW, Sydney, Australia fCentre for Youth Substance Abuse Research, University of Queensland, Brisbane, Australia gNational Addiction Centre, Kings College London, United Kingdom hSchool of Population and Global Health, University of Melbourne, Australia iMurdoch Children s Research Institute, Melbourne, Australia jDepartment of Global Health, School of Public Health, University of Washington, WA, USA
    Pain 157:1489-98. 2016
    ..Despite removal of tolerance and withdrawal for prescribed opioid use for DSM-5, we found that "Addiction" was more closely related to an ICD-11 diagnosis of pharmaceutical opioid dependence. ..
  3. doi Pharmaceutical Opioid Use and Dependence among People Living with Chronic Pain: Associations Observed within the Pain and Opioids in Treatment (POINT) Cohort
    Gabrielle Campbell
    National Drug and Alcohol Research Centre, UNSW, Sydney, New South Wales, Australia
    Pain Med 16:1745-58. 2015
    ..This article examines pharmaceutical opioid dose and dependence and examines the correlates of each...
  4. doi Defined daily doses (DDD) do not accurately reflect opioid doses used in contemporary chronic pain treatment
    Suzanne Nielsen
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia
    Pharmacoepidemiol Drug Saf . 2017
    ..To assess how well the defined daily dose (DDD) metric reflects opioid utilisation among chronic non-cancer pain patients...
  5. doi Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilization
    Suzanne Nielsen
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales, Australia The Langton Centre, South East Sydney Local Health District SESLHD Drug and Alcohol Services, Sydney, New South Wales, Australia
    Pain Med 16:356-66. 2015
    ..This article aims to: describe patterns of BZDs use; the demographic, physical, and mental health correlates of BZD use; and examine if negative health outcomes are associated with BZD use after controlling for confounders...
  6. ncbi Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation
    Louisa Degenhardt
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia
    Med J Aust 191:161-5. 2009
    ..Comparison was made with injecting of two other opioid substitution treatment medications, methadone and buprenorphine (BPN); severe harms have been documented after injection of the latter...
  7. doi Comparing treatment-seeking codeine users and strong opioid users: Findings from a novel case series
    Suzanne Nielsen
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia Drug and Alcohol Services, South Eastern Sydney Local Health District, Sydney, Australia
    Drug Alcohol Rev 34:304-11. 2015
    ....
  8. pmc Cohort protocol paper: the Pain and Opioids In Treatment (POINT) study
    Gabrielle Campbell
    National Drug and Alcohol Research Centre, UNSW, Sydney, NSW 2052, Australia
    BMC Pharmacol Toxicol 15:17. 2014
    ....
  9. doi Opioid agonist doses for oxycodone and morphine dependence: Findings from a retrospective case series
    Suzanne Nielsen
    National Drug and Alcohol Centre, University of New South Wales, Sydney, Australia
    Drug Alcohol Rev . 2016
    ..Current guidelines are based on research with heroin users. This study aimed to examine methadone and buprenorphine dose requirements for PO-dependent people...
  10. ncbi The sources of pharmaceuticals for problematic users of benzodiazepines and prescription opioids
    Suzanne Nielsen
    Discipline of Addiction Medicine, University of Sydney, Sydney, NSW, Australia
    Med J Aust 199:696-9. 2013
    ..To describe benzodiazepine and prescription opioid use by clients of drug treatment services and the sources of pharmaceuticals they use...
  11. doi Diversion of prescribed opioids by people living with chronic pain: results from an Australian community sample
    Jessica Belcher
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
    Drug Alcohol Rev 33:27-32. 2014
    ..This study investigated the extent to which an Australian community sample of chronic pain patients prescribed opioids reported supplying their prescribed opioids to others...
  12. ncbi Short-term outcomes of five heroin detoxification methods in the Australian NEPOD Project
    Erol Digiusto
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW 2052, Australia
    Addict Behav 30:443-56. 2005
    ....
  13. doi The introduction of buprenorphine-naloxone film in opioid substitution therapy in Australia: Uptake and issues arising from changing buprenorphine formulations
    Briony Larance
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
    Drug Alcohol Rev 34:603-10. 2015
    ..This study examined (i) how initiations and transfers were implemented, (ii) the profile and predictors of adverse effects as self-reported by BNX film clients, and (iii) dosing issues...
  14. doi Correlates of pain in an in-treatment sample of opioid-dependent people
    Suzanne Nielsen
    Discipline of Addiction Medicine, The University of Sydney, Sydney, Australia
    Drug Alcohol Rev 32:489-94. 2013
    ..Our hypothesis is that pain may increase aberrant opioid-related behaviours, including illicit substance use, among opioid-dependent people...
  15. pmc Study protocol: a dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependence
    Nadine Ezard
    Alcohol and Drug Service, O Brien Centre, St Vincent s Hospital, Sydney, Darlinghurst, 2010, NSW, Australia
    BMC Psychiatry 16:428. 2016
    ..The purpose of this study is to determine the safety of lisdexamfetamine in this population at doses higher than those currently approved for attention deficit hyperactivity disorder or binge eating disorder...
  16. doi Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial
    David J Allsop
    National Cannabis Prevention and Information Centre, National Drug and Alcohol Research Centre, Faculty of Medicine, University of New South Wales, Sydney, Australia2now with the School of Psychology, University of Sydney, Sydney, Australia
    JAMA Psychiatry 71:281-91. 2014
    ..There are no medications approved for treating cannabis dependence or withdrawal. The cannabis extract nabiximols (Sativex), developed as a multiple sclerosis treatment, offers a potential agonist medication for cannabis withdrawal...
  17. doi Validation and implementation of the Australian Treatment Outcomes Profile in specialist drug and alcohol settings
    Anni Ryan
    South Eastern Sydney Local Health District Drug and Alcohol Service, Sydney, Australia
    Drug Alcohol Rev 33:33-42. 2014
    ..This study aimed to psychometrically validate the Treatment Outcomes Profile under Australian conditions, examining implementation and feasibility issues in three public opioid treatment program clinics in NSW...
  18. ncbi Cessation of methadone maintenance treatment using buprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductions
    Courtney L Breen
    National Drug and Alcohol Research Centre, University of New South Wales, NSW 2052, Sydney, Australia
    Drug Alcohol Depend 71:49-55. 2003
    ..Buprenorphine is used in the treatment of opioid dependence. Due to its pharmacology, the transfer from methadone to buprenorphine may precipitate withdrawal symptoms...
  19. doi The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinic
    Parameswaran Ramasamy
    Drug Health Service, Sydney South West Area Health Service, Sydney, Australia
    Addiction 105:329-34. 2010
    ..This study examines the completion rates of a HBV vaccination schedule and seroconversion in a group of patients in methadone maintenance treatment...
  20. doi Findings and lessons learnt from implementing Australia's first health service based take-home naloxone program
    Karen J Chronister
    Kirketon Road Centre, South Eastern Sydney Local Health District, Sydney, Australia
    Drug Alcohol Rev . 2016
    ..This paper summarises findings and lessons learnt from the Overdose Prevention and Emergency Naloxone Project which is the first take-home naloxone program in Australia implemented in a health care setting...
  21. doi The Australian Treatment Outcomes Profile instrument as a clinical tool for older alcohol and other drug clients: A validation study
    Nicholas Lintzeris
    Drug and Alcohol Services, South Eastern Sydney Local Health District, Sydney, Australia
    Drug Alcohol Rev 35:673-677. 2016
    ..The aim of this study was to validate the ATOP for use in older AOD populations, by comparing it with validated 'gold standard' measures used in older populations...
  22. pmc The Effects of Lithium Carbonate Supplemented with Nitrazepam on Sleep Disturbance during Cannabis Abstinence
    David J Allsop
    School of Psychology, University of Sydney, Sydney, NSW, Australia
    J Clin Sleep Med 11:1153-62. 2015
    ..In this study we explored the effects of lithium treatment supplemented with nitrazepam on objective and subjective measures of sleep quality during inpatient cannabis withdrawal...
  23. doi Prescription of heroin for the management of heroin dependence: current status
    Nicholas Lintzeris
    Sydney South West Area Health Service, Drug Health Services, Royal Prince Alfred Hospital, Camperdown, Sydney, New South Wales, Australia
    CNS Drugs 23:463-76. 2009
    ....